BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2025.
World J Diabetes. Nov 15, 2025; 16(11): 111106
Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.111106
Table 2 Paraclinical studies of the patient with diabetes maturity-onset diabetes of the young type
Clinical laboratories
Results
Reference values (adults, conventional units)
Glycosylated hemoglobin6.8%4.0%-5.6% (normal); 5.7%-6.4% (prediabetes); ≥ 6.5% (diabetes)
Creatinine0.97 mg/dL0.6-1.3 mg/dL (women: 0.6-1.1 mg/dL, men: 0.7-1.3 mg/dL)
Urea nitrogen24.3 mg/dL7-20 mg/dL
Total cholesterol181 mg/dL< 200 mg/dL (desirable); 200-239 mg/dL (borderline); ≥ 240 mg/dL (high)
LDL cholesterol95.6 mg/dL< 100 mg/dL (optimal); 100-129 mg/dL (near optimal); ≥ 130 mg/dL (elevated)
HDL cholesterol60 mg/dL> 40 mg/dL (men); > 50 mg/dL (women); ≥ 60 mg/dL (cardioprotective)
Ionic calcium1.3 mmol/L1.12-1.32 mmol/L
C-peptide3.48 ng/mL0.8-3.1 ng/mL (fasting)
Anti-insulin, anti-islet, anti-GAD antibodiesNegativeAnti-insulin antibodies, negative, < 0.4 U/mL. Islet cell antibodies, negative, titer < 1:4; Anti-GAD antibodies, negative, < 5 U/mL


Write to the Help Desk